IN2014DN02241A - - Google Patents

Download PDF

Info

Publication number
IN2014DN02241A
IN2014DN02241A IN2241DEN2014A IN2014DN02241A IN 2014DN02241 A IN2014DN02241 A IN 2014DN02241A IN 2241DEN2014 A IN2241DEN2014 A IN 2241DEN2014A IN 2014DN02241 A IN2014DN02241 A IN 2014DN02241A
Authority
IN
India
Prior art keywords
relates
present
drug
internal standard
quantitative analysis
Prior art date
Application number
Inventor
Steven Lewis Ramsay
Wolfgang Guggenbichler
Klaus Michael Weinberger
Armin Graber
Wolfgang Markus STÖGGL
Original Assignee
Biocrates Life Sciences Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocrates Life Sciences Ag filed Critical Biocrates Life Sciences Ag
Publication of IN2014DN02241A publication Critical patent/IN2014DN02241A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/00584—Control arrangements for automatic analysers
    • G01N35/00594—Quality control, including calibration or testing of components of the analyser
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30—Data warehousing; Computing architectures
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/0027—Methods for using particle spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Databases & Information Systems (AREA)
  • Bioethics (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Quality & Reliability (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)

Abstract

The present invention relates to a device, in particular to a sample preparation device for the quantitative analysis of a drug and/ or metabolite profile in a biological sample. Moreover, the present invention relates to an insert for such a device being impregnated with at least one internal standard, to the internal standard itself, and to a kit comprising the device. Further, the present invention also relates to an apparatus containing the device, and to a method for the quantitative analysis of a drug and/or metabolite profile in a biological sample employing the device.
IN2241DEN2014 2005-06-30 2006-06-29 IN2014DN02241A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69498305P 2005-06-30 2005-06-30
US69498405P 2005-06-30 2005-06-30
PCT/EP2006/006328 WO2007003344A2 (en) 2005-06-30 2006-06-29 Device for quantitative analysis of a metabolite profile

Publications (1)

Publication Number Publication Date
IN2014DN02241A true IN2014DN02241A (en) 2015-07-10

Family

ID=36783737

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2241DEN2014 IN2014DN02241A (en) 2005-06-30 2006-06-29

Country Status (16)

Country Link
US (2) US8116983B2 (en)
EP (2) EP1897014B1 (en)
JP (2) JP4829297B2 (en)
KR (1) KR100967573B1 (en)
CN (1) CN100594501C (en)
AU (1) AU2006265381B2 (en)
BR (1) BRPI0613478B8 (en)
CA (2) CA2608963C (en)
DK (2) DK1875401T3 (en)
ES (1) ES2452025T3 (en)
IL (1) IL187470A (en)
IN (1) IN2014DN02241A (en)
NO (1) NO339319B1 (en)
NZ (1) NZ563431A (en)
RU (1) RU2391672C2 (en)
WO (2) WO2007003343A1 (en)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2158977A1 (en) 1994-05-09 1995-11-10 James G. Respess Retroviral vectors having a reduced recombination rate
US8969089B2 (en) 2004-10-12 2015-03-03 Quest Diagnostics Investments, Inc. Analysis of amino acids in body fluid by liquid chromatography-mass spectrometry
IN2014DN02241A (en) * 2005-06-30 2015-07-10 Biocrates Life Sciences Ag
EP2018566A1 (en) * 2006-05-05 2009-01-28 Perkinelmer LAS, Inc. Quantitative analysis of surface-derived samples using mass spectrometry
EP1923806A1 (en) * 2006-11-14 2008-05-21 Metanomics GmbH Fast metabolomic analysis and system therefor
US7999084B2 (en) * 2007-05-16 2011-08-16 Agilent Technologies, Inc. Devices and methods for reducing matrix effects
CA2688511A1 (en) * 2007-05-31 2008-12-04 Biocrates Life Sciences Ag Biomarker and method for determining an oxidative stress level
AU2008256444A1 (en) * 2007-05-31 2008-12-04 Biocrates Life Sciences Ag Inflammation and oxidative stress level assay
US12367163B2 (en) 2007-06-29 2025-07-22 Quest Diagnostics Investments Llc Analysis of amino acids in body fluid by liquid chromatography—mass spectrometry
EP3067692B1 (en) * 2007-06-29 2019-04-17 Quest Diagnostics Investments Incorporated Analysis of amino acids in body fluid by liquid chromatography-mass spectrometry (lc-ms)
JP5306345B2 (en) * 2007-07-26 2013-10-02 フェノメノーム ディスカバリーズ インク Methods for diagnosing, assessing risk and monitoring autism spectrum disorders
DE102007043614B3 (en) * 2007-09-13 2008-11-20 Biocrates Life Sciences Gmbh Retainer for wells of multi-corrugated plate, has support arranged in opening below retaining bar, where retainer rests with lateral outer surfaces of support bars, retaining bar and/or connecting rods against inner side of opening
WO2009043149A1 (en) * 2007-10-01 2009-04-09 Mds Analytical Technologies, A Business Unit Of Mds Inc., Doing Business Through Its Sciex Division Analysis of conjugated metabolites of alcohol consumption
US20100285593A1 (en) * 2007-11-26 2010-11-11 Waters Technologies Corporation Internal standards and methods for use in quantitatively measuring analytes in a sample
EP2297771A2 (en) * 2008-06-13 2011-03-23 Smiths Detection-Montreal Inc. Analytical instrument
GB2463401B (en) 2008-11-12 2014-01-29 Caris Life Sciences Luxembourg Holdings S A R L Characterizing prostate disorders by analysis of microvesicles
EP2192196A1 (en) 2008-11-27 2010-06-02 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Prediction of lipid-metabotype-related physiological susceptibilities
US20120058009A1 (en) 2009-03-05 2012-03-08 Hitachi High-Technologies Corporation Analyzer
KR20120027182A (en) * 2009-04-30 2012-03-21 퍼듀 리서치 파운데이션 Ion generation using wetted porous material
US9500572B2 (en) 2009-04-30 2016-11-22 Purdue Research Foundation Sample dispenser including an internal standard and methods of use thereof
ES2799327T3 (en) 2009-05-05 2020-12-16 Infandx Ag Method to diagnose suffocation
SG176655A1 (en) * 2009-06-02 2012-01-30 Biocrates Life Sciences Ag New biomarkers for assessing kidney diseases
EP2507393A4 (en) 2009-11-30 2013-05-01 Caris Life Sciences Luxembourg Holdings Methods and systems for isolating, storing, and analyzing vesicles
EP2524059A4 (en) 2010-01-13 2013-11-20 Caris Life Sciences Luxembourg Holdings Detection of gastrointestinal disorders
US9128101B2 (en) 2010-03-01 2015-09-08 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
US9469876B2 (en) 2010-04-06 2016-10-18 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for metastatic prostate cancer
CN103052872B (en) * 2010-10-29 2015-05-06 Atonarp株式会社 Sampling apparatus
HUE055674T2 (en) 2010-10-29 2021-12-28 Thermo Fisher Scientific Oy System layout for an automated system for sample preparation and analysis
EP2492690A1 (en) * 2011-02-22 2012-08-29 BIOCRATES Life Sciences AG Method and use of metabolites for the diagnosis of inflammatory brain injury in preterm born infants
EP2587264A1 (en) 2011-10-25 2013-05-01 InfanDx AG Method and use of metabolites for the diagnosis and differentiation of neonatal encephalopathy
JP6444736B2 (en) 2011-11-23 2018-12-26 クエスト ダイアグノスティックス インヴェストメンツ インコーポレイテッド Detection of kisspeptin-54 by tandem mass spectrometry
JP6198408B2 (en) * 2012-04-02 2017-09-20 株式会社日立ハイテクノロジーズ Method for analyzing volatile substances in sample liquid
US8870028B2 (en) 2012-05-25 2014-10-28 Restek Corporation Dispensing device
WO2014026991A1 (en) * 2012-08-13 2014-02-20 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Biomarkers for type 2 diabetes
EP2917738A1 (en) 2012-11-12 2015-09-16 BIOCRATES Life Sciences AG Use of quality indicators for checking thawing processes in frozen sample tissues
WO2014110196A1 (en) * 2013-01-10 2014-07-17 Restek Corporation Dispensing device and method
BR112015018484A2 (en) 2013-01-31 2017-07-18 Purdue Research Foundation methods of analyzing crude oil
CN104956462B (en) 2013-01-31 2017-10-10 普度研究基金会 For analyzing the system and method for extracting sample
EP3014647B1 (en) 2013-06-25 2018-12-19 Purdue Research Foundation Mass spectrometry analysis of microorganisms in samples
CN103558354B (en) * 2013-11-15 2015-07-15 南京大学 Water toxicity analysis method based on biologic omics integrated technology
JP2017101924A (en) * 2014-03-31 2017-06-08 積水メディカル株式会社 Internal standard substance reagent
CN104200087B (en) * 2014-06-05 2018-10-02 清华大学 Method and system for parameter optimization and feature tuning for machine learning
US9786478B2 (en) 2014-12-05 2017-10-10 Purdue Research Foundation Zero voltage mass spectrometry probes and systems
CN113725063B (en) 2015-02-06 2024-09-20 普度研究基金会 Probes, cartridges, systems, and methods for sample analysis
EP3171173A1 (en) 2015-11-19 2017-05-24 Medizinische Universität Innsbruck Method of diagnosis of a thoracic aortic aneurysm
US10001501B2 (en) 2015-12-31 2018-06-19 Universal Diagnostics, S. L. Systems and methods for automated, customizable sample preparation for detection of metabolites and lipids
DE102017112612A1 (en) * 2016-06-10 2017-12-14 Hitachi High-Tech Science Corporation A liquid chromatograph and method for correcting variations in a detector output of the liquid chromatograph
US10607723B2 (en) 2016-07-05 2020-03-31 University Of Kentucky Research Foundation Method and system for identification of metabolites using mass spectra
WO2018085835A1 (en) 2016-11-07 2018-05-11 Battelle Memorial Institute Nanoscale biochemical sample preparation and analysis
US11719702B2 (en) * 2016-11-07 2023-08-08 Battelle Memorial Institute Methods and systems of proteome analysis and imaging
EP3351938A1 (en) 2017-01-18 2018-07-25 BIOCRATES Life Sciences AG New biomarkers for assessing ovarian cancer
EP3376230A1 (en) 2017-03-13 2018-09-19 Biocross, S.L. Identification of signatures for neurodegeneration diseases diagnoses
WO2018174876A1 (en) * 2017-03-22 2018-09-27 Mprobe Inc. Methods and compositions for providing a preeclampsia assessment with metabolites
CN107727850B (en) * 2017-10-10 2021-08-27 常州博闻迪医药股份有限公司 Lateral flow chromatography detection reaction start control method
JP6991436B2 (en) * 2017-05-17 2022-01-12 ラジオメーター・メディカル・アー・ペー・エス Porous optical fiber for detecting specimens in fluids
CN107561150A (en) * 2017-07-03 2018-01-09 宁波华仪宁创智能科技有限公司 The detection method of drug abuse
CN107798981A (en) * 2017-10-31 2018-03-13 楚雄医药高等专科学校 A kind of permanent teaching micro-capsule sample slice and preparation method thereof
CN109030673A (en) * 2018-07-04 2018-12-18 易达精准（杭州）科技有限公司 The detection method and detection kit of immunosuppressor in dried blood spot
CN109298115B (en) * 2018-10-19 2020-07-28 深圳市绘云生物科技有限公司 Quantitative detection method for multiple metabolites in biological sample and metabolic chip
WO2020099683A1 (en) 2018-11-16 2020-05-22 Biocrates Life Sciences Ag Metabolites for use in ovarian cancer detection and diagnosis
FR3091351B1 (en) 2018-12-27 2021-05-21 Univ Rouen Centre Hospitalier FABRY'S DISEASE BIOMARKER
KR102035162B1 (en) * 2019-03-12 2019-11-08 한국과학기술원 Method for predicting drug candidate for diseases by using human metabolite specific for the disease target metabolizing enzyme
GB201916046D0 (en) * 2019-11-04 2019-12-18 Amazentis Sa Diagnostic method
CN111579665B (en) * 2020-05-20 2021-11-05 苏州帕诺米克生物医药科技有限公司 UPLC/HRMS-based metabonomics relative quantitative analysis method
US20230204544A1 (en) * 2020-05-21 2023-06-29 Mayo Foundation For Medical Education And Research Calibration methods for mass spectrometry measurements
CN111704654B (en) * 2020-06-18 2021-12-03 上海交通大学医学院附属仁济医院 Peptide compound and preparation method and application thereof
US11754536B2 (en) 2021-11-01 2023-09-12 Matterworks Inc Methods and compositions for analyte quantification
US12100484B2 (en) 2021-11-01 2024-09-24 Matterworks Inc Methods and compositions for analyte quantification
JP7206365B1 (en) 2021-12-22 2023-01-17 浜松ホトニクス株式会社 sample support
KR102547430B1 (en) * 2022-11-16 2023-06-23 (주)애터미오롯 Method for qualitative analysis of noni-containing composition
WO2024123681A2 (en) * 2022-12-05 2024-06-13 Washington University Improved method for scalable untargeted metabolomic workflow
GB2636339A (en) 2023-08-30 2025-06-18 Cambridge Entpr Ltd Biomarkers for bipolar disorder
CN117538530B (en) * 2023-11-07 2024-07-19 中国医学科学院肿瘤医院 A biomarker composition and kit for detecting metastatic breast cancer and its application

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017155C1 (en) * 1993-05-05 1994-07-30 Геннадий Степанович Власов Diagnostic device for immunochemical assay
US5756362A (en) * 1993-10-12 1998-05-26 Cornell Research Foundation, Inc. Liposome-enhanced immunoaggregation assay and test device
US6358752B1 (en) 1996-09-27 2002-03-19 Cornell Research Foundation, Inc. Liposome-enhanced test device and method
GB9718129D0 (en) * 1997-08-27 1997-10-29 Isis Innovation Branched structures
US6258605B1 (en) * 1999-03-26 2001-07-10 Neo Gen Screening, Inc. Clinical method for the genetic screening of newborns using tandem mass spectrometry
US6455321B1 (en) 1999-01-30 2002-09-24 Neo Gen Screening, Inc. Method for interpreting tandem mass spectrometry data for clinical diagnosis
US20020009394A1 (en) * 1999-04-02 2002-01-24 Hubert Koster Automated process line
EP1113269B1 (en) 1999-12-29 2006-10-18 PerkinElmer Life Sciences, Inc. Test tray, kit and methods for screening body fluids of newborns by tandem mass spectrometry
WO2001078652A2 (en) * 2000-04-14 2001-10-25 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US6680203B2 (en) 2000-07-10 2004-01-20 Esperion Therapeutics, Inc. Fourier transform mass spectrometry of complex biological samples
JP2004518944A (en) * 2000-07-18 2004-06-24 インヴィトロジェン コーポレーション Apparatus and method for fractionating and filtering gel material to extract molecules
US6627444B1 (en) * 2000-08-07 2003-09-30 Smiths Detection - Toronto Ltd. Method and solid phase calibration sample for calibration of analytical instructions
US20020155587A1 (en) * 2001-04-20 2002-10-24 Sequenom, Inc. System and method for testing a biological sample
CA2452660A1 (en) 2001-07-06 2003-01-16 Lipomics Technologies, Inc. Generating, viewing, interpreting, and utilizing a quantitative database of metabolites
CA2457695A1 (en) 2001-08-14 2003-02-27 President And Fellows Of Harvard College Absolute quantification of proteins and modified forms thereof by multistage mass spectrometry
US6929944B2 (en) 2001-08-31 2005-08-16 Beckman Coulter, Inc. Analysis using a distributed sample
US6939716B2 (en) * 2001-09-19 2005-09-06 Washington University Method for detecting conditions indicative of sepsis
EP1446667A2 (en) * 2001-11-13 2004-08-18 Caprion Pharmaceuticals, Inc. Mass intensity profiling system and uses thereof
US20040023295A1 (en) 2001-11-21 2004-02-05 Carol Hamilton Methods and systems for analyzing complex biological systems
GB0128498D0 (en) * 2001-11-28 2002-01-23 Inst Of Child Health International standards for sphingolipids
JP4767496B2 (en) 2001-12-08 2011-09-07 マイクロマス ユーケー リミテッド Mass spectrum measurement method
AUPS177202A0 (en) 2002-04-16 2002-05-23 Diakyne Pty Ltd Multi-element screening of trace elements
WO2004038602A1 (en) 2002-10-24 2004-05-06 Warner-Lambert Company, Llc Integrated spectral data processing, data mining, and modeling system for use in diverse screening and biomarker discovery applications
WO2004038381A2 (en) 2002-10-25 2004-05-06 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US20040119010A1 (en) * 2002-11-01 2004-06-24 The Regents Of The University Of Colorado Quantitative analysis of protein isoforms using matrix-assisted laser desorption/ionization time of flight mass spectrometry
US20040121305A1 (en) * 2002-12-18 2004-06-24 Wiegand Roger Charles Generation of efficacy, toxicity and disease signatures and methods of use thereof
US6909981B2 (en) * 2003-01-27 2005-06-21 Ciphergen Biosystems, Inc. Data management system and method for processing signals from sample spots
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
AU2004276760B2 (en) 2003-09-22 2010-03-04 Becton, Dickinson And Company Quantification of analytes using internal standards
KR20050050714A (en) * 2003-11-26 2005-06-01 매그나칩 반도체 유한회사 Method for fabricating transistor of semiconductor device
US7745226B2 (en) * 2005-04-06 2010-06-29 Quest Diagnostics Investments Incorporated Methods for detecting vitamin D metabolites
IN2014DN02241A (en) * 2005-06-30 2015-07-10 Biocrates Life Sciences Ag

Also Published As

Publication number Publication date
KR100967573B1 (en) 2010-07-05
US8116983B2 (en) 2012-02-14
WO2007003344A3 (en) 2007-04-26
EP1897014A1 (en) 2008-03-12
AU2006265381B2 (en) 2010-06-10
EP1875401B1 (en) 2014-03-05
JP4829297B2 (en) 2011-12-07
CA2608963A1 (en) 2007-01-11
CA2608965C (en) 2014-08-19
WO2007003344A2 (en) 2007-01-11
IL187470A (en) 2015-02-26
AU2006265381A1 (en) 2007-01-11
US8265877B2 (en) 2012-09-11
NO339319B1 (en) 2016-11-28
IL187470A0 (en) 2008-03-20
CN101208697A (en) 2008-06-25
BRPI0613478B8 (en) 2021-07-27
ES2452025T3 (en) 2014-03-31
DK1897014T3 (en) 2014-03-10
RU2008102835A (en) 2009-08-10
BRPI0613478B1 (en) 2019-07-09
EP1875401A2 (en) 2008-01-09
JP2008547030A (en) 2008-12-25
JP2008547031A (en) 2008-12-25
RU2391672C2 (en) 2010-06-10
DK1875401T3 (en) 2014-04-07
BRPI0613478A2 (en) 2012-01-17
US20070003965A1 (en) 2007-01-04
JP5155160B2 (en) 2013-02-27
US20070004044A1 (en) 2007-01-04
CA2608965A1 (en) 2007-01-11
NZ563431A (en) 2012-05-25
CN100594501C (en) 2010-03-17
EP1897014B1 (en) 2014-01-15
CA2608963C (en) 2014-08-26
WO2007003343A1 (en) 2007-01-11
KR20080025092A (en) 2008-03-19
NO20080559L (en) 2008-01-30

Similar Documents

Publication Publication Date Title
IN2014DN02241A (en)
WO2008039946A3 (en) Integrated meter for analyzing biological samples
EP1882950A4 (en) Testing chip for analyzing target substance contained in analyte, and microscopic comprehensive analytical system
GB2474146A (en) Methods of determining the health status of an individual
AU2013207599A1 (en) Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof
GB2439032B (en) Method and system for sample testing
EP1867978A4 (en) Method of analyte analysis and analyte analyzer
WO2010048431A3 (en) Device, method and apparatus for analysing skin and hair
WO2007114986A3 (en) Cooperative probes and methods of using them
AU2006316189A8 (en) Novel quantitative and qualitative analysis apparatus for measuring the body fluid
WO2005067582A3 (en) Methods and apparatus for enhanced sample identification based on combined analytical techniques
EP2772761A3 (en) Nucleic acid element for use in analysis, and analytical method, analytical reagent and analytical instrument using same
EP1819283A4 (en) System and method for analyte sampling and analysis with hydrogel
GB0424960D0 (en) Improved method of electrochemical analysis of an analyte
EP1939611A4 (en) Method for detecting sample supply condition, and analyzer
WO2009142835A3 (en) Method and apparatus for analyzing skin and hair
GB2440470B (en) Devices and methods for sample collection and analysis
ZA201001253B (en) Reagent kit for sample analysis and sample analysis method
GB0507457D0 (en) Improvements in or relating to methods and apparatus for analyzing biological samples by mass spectrometry
IL191053A0 (en) Devices and methods for sample collection and analysis
IL212082A0 (en) Device, kit and method for pulsing biological samples with an agent and stabilising the sample so pulsed
DE602005015559D1 (en) PHARMACODYNAMIC TESTS WITH FLOW CYTOMETRY
ZA200800253B (en) Method for the quantitative determination of poloxamers
WO2008072275A3 (en) Telematic system for using diagnostic reagent strips and method for acquiring calibration data
EP1917516A4 (en) Preparing biological samples for analysis